The European Pharmaceutical Commission has approved the circulation of the world's first Ervebo vaccine (rVSV -G-ZEBOV-GP) to prevent Ebola.
Information published in the US issue of Science Translational Medicine over the weekend.
Doctors at Siriraj Hospital in Thailand have just announced that they have successfully developed an antibody for the treatment of Ebola that is at risk of becoming a
Researchers at the US National Institutes of Health (NIH) are preparing to conduct a human clinical trial of a new prospective Ebola virus vaccine, nearly a month earlier than
Two Americans who have been infected with Liberia's Ebola virus have been declared to have been successfully treated and there is no deadly pathogen in the body.